AGILE: Coronavirus drug testing initiative

With a mission to shorten the time taken to identify safe, effective and affordable treatments for COVID-19, AGILE is a collaboration between the University of Liverpool, LSTM, the Southampton Clinical Trials Unit, and other external partners.

The team includes Infectious Diseases clinicians, clinical and pre-clinical pharmacologists, clinical trials specialists and statisticians, each bringing a unique set of skills and expertise to design the best platform possible.